Is Omalizumab Related to Ear and Labyrinth Disorders? A Disproportionality Analysis Based on a Global Pharmacovigilance Database.

Hyeon Tae Park Sunny Park Yong Woo Jung Soo An Choi

Published in: Diagnostics (Basel, Switzerland) (2022)

Careful monitoring of ear disorders is recommended when omalizumab treatment is started, with decreased oral corticosteroid use in patients with severe asthma. Further studies are necessary to confirm the omalizumab-related signals.

Keyphrases

adverse drug
emergency department
drug induced